arrow
A

Andreas Kleinheinz

elbe-klinikum buxtehude
H指数:23
被引数:3,096

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Keratinocyte Priming by Staphylococcus aureus Reduces HSV-1 Susceptibility

金黄色葡萄球菌对角质形成细胞的预刺激降低了HSV-1的易感性

2026-05-200
OA
Performance of omalizumab in patients with mast cell-mediated angioedema with and without wheals

奥马珠单抗在肥大细胞介导的有或无风团的血管性水肿患者中的疗效

2026-03-120
OAAI
Klinisches und immunpathologisches Spektrum des Immunglobulin-M-Pemphigoids: eine multizentrische Fallserie

IgM型天疱疮的临床和免疫病理谱:一项多中心病例系列

2025-12-110
OAAI
Clinical and immunopathological spectrum of immunoglobulin M pemphigoid: a multicenter case series

免疫球蛋白M类天疱疮的临床和免疫病理学谱:一项多中心病例系列研究

2025-08-060
OA
Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real-world data from a large multi-national UCARE study
2024-10-080
OAAI
Multinational Drug Survival Study of Omalizumab in Patients With Chronic Urticaria and Potential Predictors for Discontinuation
2024-09-014
PRE
Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study
2023-11-018
PRE
High recurrence rate of eczema herpeticum in moderate/severe atopic dermatitis - TREATgermany registry analysis

中/重度特应性皮炎中湿疹疱疹的高复发率-treategermany注册分析

2023-10-094
OAAI
Itch, sleep loss, depressive symptoms, fatigue, and productivity loss in patients with moderate-to-severe atopic dermatitis: Analyses of TREATgermany registry data

中度至重度特应性皮炎患者的瘙痒,睡眠不足,抑郁症状,乏力和生产力下降: treategermany注册数据分析

2023-07-239
OAAI
A global, observational, cohort study of patients with atopic dermatitis to evaluate tralokinumab real-world clinical use (TRACE): baseline characteristics from the first 100 patients in Germany

一项针对特应性皮炎患者的全球观察性队列研究,以评估tralokinumab的真实世界临床使用 (TRACE): 德国首批100例患者的基线特征

2023-06-201
PRE
Dupilumab but not cyclosporine treatment shifts the microbiome toward a healthy skin flora in patients with moderate-to-severe atopic dermatitis

Dupilumab而非环孢素治疗将中度至重度特应性皮炎患者的微生物群转向健康的皮肤菌群

2023-04-1812
OA
Itching in Atopic Dermatitis: Patient- and Physician-reported Outcomes in the German Atopic Dermatitis Registry TREATgermany

特应性皮炎中的瘙痒:德国特应性皮炎登记库TREATgermany中患者与医师报告的结局

2023-01-2321
OAAI
Real-world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry

关于dupilumab的有效性,安全性和药物生存期的真实数据: 来自TREATgermany注册中心的分析

2022-12-0113
OA
Itching and treatments in atopic dermatitis (AD): results from the German AD registry TREATgermany

特应性皮炎 (AD) 的瘙痒和治疗: 来自德国AD登记处的结果

2022-11-173
PRE
Perception of the coronavirus pandemic by patients with atopic dermatitis - Results from the TREATgermany registry

特应性皮炎患者对冠状病毒大流行的看法-来自TREATgermany注册表的结果

2021-12-273
PREAI
Atopic dermatitis: disease characteristics and comorbidities in smoking and non-smoking patients from the TREATgermany registry
2021-11-3012
OA